| abstract |
The present invention relates to a pharmaceutical composition for administration of the active ingredient causing inflammation of the upper gastrointestinal tract. This dosage contains an inflammatory active ingredient and an ion exchange resin. The dosages protect tissues of the oral cavity, pharynx, esophagus and gastrointestinal tract from erosions and ulcers that occur as tissues are exposed to inflammatory active ingredients. |